Karen Bernstein

Insider Reports History

Entity
Individual
Location
C/O Vitae Pharmaceuticls, Inc., 502 West Office Center Drive, Fort Washington, PA
Signature
/s/ Chris Matteodo, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karen Bernstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ovid Therapeutics Inc. Director Stock Option (Right to Buy) 90K Dec 12, 2024 Direct
Codiak BioSciences, Inc. Director Common Stock 8.75K Feb 16, 2023 Indirect
Codiak BioSciences, Inc. Director Restricted Stock Units 0 Feb 16, 2023 Indirect

Insider Reports Filed by Karen Bernstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OVID Ovid Therapeutics Inc. Dec 12, 2024 1 $0 4 Dec 16, 2024 Director
OVID Ovid Therapeutics Inc. Feb 22, 2024 1 $0 4 Feb 26, 2024 Director
OVID Ovid Therapeutics Inc. Feb 23, 2023 1 $0 4 Feb 27, 2023 Director
CDAKQ Codiak BioSciences, Inc. Feb 16, 2023 2 $0 4 Feb 21, 2023 Director
CDAKQ Codiak BioSciences, Inc. Jun 17, 2022 2 $0 4 Jun 21, 2022 Director
OVID Ovid Therapeutics Inc. Apr 8, 2022 1 $0 4 Apr 12, 2022 Director
CDAKQ Codiak BioSciences, Inc. Feb 16, 2022 1 $0 4 Feb 18, 2022 Director
OVID Ovid Therapeutics Inc. Feb 3, 2022 1 $0 4 Feb 4, 2022 Director
CDAKQ Codiak BioSciences, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director
OVID Ovid Therapeutics Inc. Jun 11, 2021 1 $0 4 Jun 11, 2021 Director
OVID Ovid Therapeutics Inc. May 17, 2021 1 $0 4 May 18, 2021 Director